UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007475 |
|---|---|
| Receipt number | R000008808 |
| Scientific Title | A randomized phase II study of Erlotinib with or without Bevacizumab in NSCLC patients previouly treated with platinum-based chemotherapy containing bevacizumab. North Japan Lung Cancer Study Group Trial 1201 |
| Date of disclosure of the study information | 2012/03/09 |
| Last modified on | 2014/09/09 11:51:33 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/03/09 16:37:52 | ||
| 2 | Update | 2012/03/29 08:58:34 | Recruitment status |
|
| 3 | Update | 2013/01/07 16:50:11 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2013/03/01 12:48:41 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
| 5 | Update | 2013/03/11 12:51:10 | Email1 |
|
| 6 | Update | 2013/09/09 12:42:53 | Address TEL Address Address TEL Address |
|
| 7 | Update | 2014/09/09 11:51:33 | Recruitment status |
